Macrophages suppress cardiac reprogramming of fibroblasts in vivo via IFN-mediated intercellular self-stimulating circuit

Abstract

Direct conversion of cardiac fibroblasts (CFs) to cardiomyocytes (CMs) in vivo to regenerate heart tissue is an attractive approach. After myocardial infarction (MI), heart repair proceeds with an inflammation stage initiated by monocytes infiltration of the infarct zone establishing an immune microenvironment. However, whether and how the MI microenvironment influences the reprogramming of CFs remains unclear. Here, we found that in comparison with cardiac fibroblasts (CFs) cultured in vitro, CFs that transplanted into infarct region of MI mouse models resisted to cardiac reprogramming. RNA-seq analysis revealed upregulation of interferon (IFN) response genes in transplanted CFs, and subsequent inhibition of the IFN receptors increased reprogramming efficiency in vivo. Macrophage-secreted IFN-β was identified as the dominant upstream signaling factor after MI. CFs treated with macrophage-conditioned medium containing IFN-β displayed reduced reprogramming efficiency, while macrophage depletion or blocking the IFN signaling pathway after MI increased reprogramming efficiency in vivo. Co-IP, BiFC and Cut-tag assays showed that phosphorylated STAT1 downstream of IFN signaling in CFs could interact with the reprogramming factor GATA4 and inhibit the GATA4 chromatin occupancy in cardiac genes. Furthermore, upregulation of IFN-IFNAR-p-STAT1 signaling could stimulate CFs secretion of CCL2/7/12 chemokines, subsequently recruiting IFN-β-secreting macrophages. Together, these immune cells further activate STAT1 phosphorylation, enhancing CCL2/7/12 secretion and immune cell recruitment, ultimately forming a self-reinforcing positive feedback loop between CFs and macrophages via IFN-IFNAR-p-STAT1 that inhibits cardiac reprogramming in vivo. Cumulatively, our findings uncover an intercellular self-stimulating inflammatory circuit as a microenvironmental molecular barrier of in situ cardiac reprogramming that needs to be overcome for regenerative medicine applications.

Keywords

cardiac reprogramming / heart regeneration / microenvironment / Ifnar1/2

References

[1] Abe Y, Tani H, Sadahiro T et al. Cardiac reprogramming reduces inflammatory macrophages and improves cardiac function in chronic myocardial infarction. Biochem Biophys Res Commun 2023;690:149272.

[2] Addis RC, Ifkovits JL, Pinto F et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol 2013;60:97–106.

[3] Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus 2005;14:S2–S8.

[4] Ambrosy AP, Fonarow GC, Butler J et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure regis-tries. J Am Coll Cardiol 2014;63:1123–1133.

[5] Auphan N, DiDonato JA, Rosette C et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (New York, NY) 1995;270:286–290.

[6] Bai M, Sun R, Cao B et al. Monocyte-related cytokines/chemokines in cerebral ischemic stroke. CNS Neurosci Ther 2023;29:3693–3712.

[7] Bejleri D, Streeter BW, Nachlas ALY et al. A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart Repair. Adv Healthc Mater 2018;7:e1800672.

[8] Decano JL, Maiorino E, Matamalas JT et al. Cellular heterogeneity of activated primary human macrophages and associated drug-gene networks: from biology to precision therapeutics. Circulation 2023;148:1459–1478.

[9] Dewald O, Zymek P, Winkelmann K et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005;96:881–889.

[10] de Weerd NA, Nguyen T. The interferons and their receptors—distribution and regulation. Immunol Cell Biol 2012;90:483–491.

[11] Dirkx E, Gladka MM, Philippen LE et al. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol 2013;15:1282–1293.

[12] Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159–173.

[13] Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014;11:255–265.

[14] Fu X, Khalil H, Kanisicak O et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest 2018;128:2127–2143.

[15] Garry GA, Bezprozvannaya S, Chen K et al. The histone reader PHF7 cooperates with the SWI/SNF complex at cardiac super enhancers to promote direct reprogramming. Nat Cell Biol 2021;23:467–475.

[16] Grabie N, Gotsman I, DaCosta R et al. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+T-cell mediated injury in the heart. Circulation 2007;116:2062–2071.

[17] Guo Y, Lei I, Tian S et al. Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming. J Biol Chem 2019;294:9134–9146.

[18] Hashimoto H, Wang Z, Garry GA et al. Cardiac reprogramming factors synergistically activate genome-wide cardiogenic stage-specific enhancers. Cell Stem Cell 2019;25:69–86 e65.

[19] Hodgkinson CP, Pratt RE, Kirste I et al. Cardiomyocyte maturation requires TLr3 activated nuclear factor Kappa B. Stem Cells 2018;36:1198–1209.

[20] Hulsmans M, Sager HB, Roh JD et al. Cardiac macrophages promote diastolic dysfunction. J Exp Med 2018;215:423–440.

[21] Humeres C, Frangogiannis NG. Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl Sci 2019;4:449–467.

[22] Ieda M, Fu JD, Delgado-Olguin P et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375–386.

[23] Inagawa K, Miyamoto K, Yamakawa H et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, MeF2c, and Tbx5. Circ Res 2012;111:1147–1156.

[24] Isomi M, Sadahiro T, Yamakawa H et al. Overexpression of Gata4, MeF2c, and Tbx5 generates induced cardiomyocytes via direct reprogramming and rare fusion in the heart. Circulation 2021;143:2123–2125.

[25] Izadifar M, Chapman D, Babyn P et al. UV-Assisted 3D bioprinting of nanoreinforced hybrid cardiac patch for myocardial tissue engineering. Tissue Eng Part C Methods 2018;24:74–88.

[26] Jayawardena TM, Egemnazarov B, Finch EA et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012;110:1465–1473.

[27] Jayawardena TM, Finch EA, Zhang L et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res 2015;116:418–424.

[28] Kanisicak, O, Khalil, H, Ivey, MJ et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun 2016;7:12260.

[29] Kawamura M, Miyagawa S, Miki K et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012;126:S29–S37.

[30] King KR, Aguirre AD, Ye YX et al. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med 2017;23:1481–1487.

[31] Knott JG, Ifkovits JL, Addis RC et al. Inhibition of TGFβsignaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS One 2014;9:e89678.

[32] Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845–856.

[33] Li J, Hu S, Zhu D, Huang K et al. All Roads lead to Rome (the heart): cell retention and outcomes from various delivery routes of cell therapy products to the heart. J Am Heart Assoc 2021a;10:e020402.

[34] Li C, Wang H, Yin Z et al. Ligand-induced native G-quadruplex stabilization impairs transcription initiation. Genome Res 2021b;31:1546–1560.

[35] Lin X, Liu Y, Bai A et al. A viscoelastic adhesive epicardial patch for treating myocardial infarction. Nat Biomed Eng 2019;3:632–643.

[36] Liu Z, Chen O, Zheng M et al. Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast con-version into induced cardiomyocytes. Stem Cell Res 2016;16:507–518.

[37] Liu Z, Wang L, Welch JD et al. Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte. Nature 2017;551:100–104.

[38] Liu L, Guo Y, Li Z et al. Improving cardiac reprogramming for heart regeneration in translational medicine. Cells 2021;10:3297.

[39] Ma CX, Song YL, Xiao L et al. EGF is required for cardiac differentiation of P19CL6 cells through interaction with GATA-4 in a time-and dose-dependent manner. Cell Mol Life Sci 2015;72:2005–2022.

[40] Ma Y, Mouton AJ, Lindsey ML. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res 2018;191:15–28.

[41] Miyamoto K, Akiyama M, Tamura F et al. Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction. Cell Stem Cell 2018;22:91–103.e5 e105.91.

[42] Mohamed TM, Stone NR, Berry EC et al. Chemical enhancement of in vitro and in vivo direct cardiac reprogramming. Circulation 2017;135:978–995.

[43] Mohamed TMA, Ang YS, Radzinsky E et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 2018;173:104–116.e12.

[44] Mohr ME, Li S, Trouten AM et al. Cardiomyocyte-fibroblast interaction regulates ferroptosis and fibrosis after myocardial injury. bioRxiv: The Preprint Server For Biol 2023:

[45] Molero-Díez YB, Sánchez-Tabernero A, Ruiz-Simón FA et al. Fourth universal definition of myocardial infarction. Col J Anesthesiol 2019;47:175–177.

[46] Mosteiro L, Pantoja C, de Martino A et al. Senescence promotes in vivo reprogramming through p16(INK)(4a) and IL-6. Aging Cell 2018;17:e12711.

[47] Muraoka N, Yamakawa H, Miyamoto K et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 2014;33:1565–1581.

[48] Muraoka N, Nara K, Tamura F et al. Role of cyclooxygenase-2-mediated prostaglandin e2-prostaglandin E receptor 4 signaling in cardiac reprogramming. Nat Commun 2019;10:674.

[49] Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010;121:2437–2445.

[50] Nakada Y, Canseco DC, Thet S et al. Hypoxia induces heart regeneration in adult mice. Nature 2017;541:222–227.

[51] Ngwenyama N, Salvador AM, Velazquez F et al. CXCr3 regulates CD4+T cell cardiotropism in pressure overload-induced cardiac dysfunction. JCI Insight 2019;4:e125527.

[52] Palacios D, Mozzetta C, Consalvi S et al. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010;7:455–469.

[53] Patel B, Bansal SS, Ismahil MA et al. CCr2(+) Monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. JACC Basic Transl Sci 2018;3:230–244.

[54] Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 2016;119:91–112.

[55] Protze S, Khattak S, Poulet C et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 2012;53:323–332.

[56] Qiao H, Zhang H, Yamanaka S et al. Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imaging 2011;4:33–41.

[57] Shiba Y, Gomibuchi T, Seto T et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 2016;538:388–391.

[58] Song K, Nam Y-J, Luo X et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012;485:599–604.

[59] Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res 2016;365:563–581.

[60] Tani H, Sadahiro T, Yamada Y et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation 2023;147:223–238.

[61] Tao G, Kahr PC, Morikawa Y et al. Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury. Nature 2016;534:119–123.

[62] Tao Y, Yang Y, Yang Z et al. Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblasts. iScience 2023;26:108466.

[63] Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit 1995;17:584–591.

[64] van Amerongen MJ, Harmsen MC, van Rooijen N et al. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007;170:818–829.

[65] van Rooijen N, Hendrikx E. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol (Clifton, NJ) 2010;605:189–203.

[66] Vaseghi H, Liu J, Qian L. Molecular barriers to direct cardiac reprogramming. Protein Cell 2017;8:724–734.

[67] Virag JA, Lust RM. Coronary artery ligation and intramyocardial injection in a murine model of infarction. J Vis Exp 2011:2581.

[68] Wang J, Paradis P, Aries A et al. Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 2005;25:9829–9844.

[69] Wang L, Liu Z, Yin C et al. Stoichiometry of Gata4, MeF2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res 2015;116:237–244.

[70] Wang X, Shi H, Huang S et al. Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction. Biomaterials 2023;302:122364.

[71] Xu S, Xie F, Fallah S et al. (2020). Estrogen accelerates heart regeneration by promoting the inflammatory response in zebrafish. J Endocrinol 245, 39–51.

[72] Yamakawa H, Muraoka N, Miyamoto K et al. Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions. Stem Cell Rep 2015;5:1128–1142.

[73] Yerra VG, Batchu SN, Kaur H et al. Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure. J Clin Investig 2023;133:e161453.

[74] Zhao Y, Londono P, Cao Y et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun 2015;6:8243.

[75] Zhao H, Zhang Y, Xu X et al. Sall4 and myocd empower direct cardiac reprogramming from adult cardiac fibroblasts after injury. Front Cell Dev Biol 2021;9:608367.

[76] Zhou H, Dickson ME, Kim MS et al. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes. Proc Natl Acad Sci U S A 2015;112:11864–11869.

[77] Zhou Y, Wang L, Vaseghi HR et al. Bmi1 is a key epigenetic barrier to direct cardiac reprogramming. Cell Stem Cell 2016;18:382–395.

[78] Zhou H, Morales MG, Hashimoto H et al. ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression. Genes Dev 2017;31:1770–1783.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.